Showing results (31-40 of 2,054) with videos related to

Sort By:
Pageof 206
Brachytherapy|August 1, 2016
New objective method in reporting the breast cosmesis after breast-conservative treatment based on nonstandardized photographs: The Objective Breast Cosmesis ScaleTamer Soror, György Kovács, Ádám Kovács, et al.
Brachytherapy|July 4, 2015
CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapyLihong Yao, Yuliang Jiang, Ping Jiang, et al.
Brachytherapy|July 19, 2015
Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancerJulie K Schwarz, Sushil Beriwal, Jacqueline Esthappan, et al.
Brachytherapy|June 9, 2015
Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trialsGregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Brachytherapy|June 9, 2015
Assessing changes to the brachytherapy target for cervical cancer using a single MRI and serial ultrasoundSylvia van Dyk, Srinivas Kondalsamy-Chennakesavan, Michal Schneider, et al.
Brachytherapy|June 9, 2015
Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective reviewDavid Thomas Vonk, Yongbok Kim, Cameron Javid, et al.
Brachytherapy|June 16, 2015
Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modelingAndrew W Browne, Savita V Dandapani, Richard Jennelle, et al.
Brachytherapy|June 17, 2015
Anthropomorphic phantom to investigate the bladder dose in gynecological high-dose-rate brachytherapyR M V Silva, W Belinato, L E Macedo, et al.
Brachytherapy|June 21, 2015
A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancerManju Sharma, Emma C Fields, Dorin A Todor
Brachytherapy|February 7, 2018
Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer-A randomized controlled trial of alpha-1 adrenoceptor antagonist alone versus combination with cyclooxygenase-2 inhibitorNobumichi Tanaka, Kazumasa Torimoto, Isao Asakawa, et al.
Pageof 206